Immunotherapy Safely Treats Advanced Squamous Cell Carcinoma
An anti –PD-1 monoclonal antibody is safe and effective for patients with unresectable, locally advanced, or metastatic cutaneous squamous cell carcinoma.
Source: CancerNetwork - Category: Cancer & Oncology Authors: Mark L. Fuerst Tags: News Skin Cancer (Nonmelanoma) Source Type: news
More News: Cancer | Cancer & Oncology | Carcinoma | Immunotherapy | Nonmelanoma Skin Cancer | Skin | Skin Cancer | Squamous Cell Carcinoma
MedWorm Privacy Policy
Disclaimer
Copyright © MedWorm 2006-2024